UK Regulator Rules on La Roche-Posay over "No.1 Dermatologist Recommended" Claim

The Advertising Standards Authority (ASA) in the UK recently concluded an investigation into promotional materials for La Roche-Posay's Mela B3 Cleanser. The inquiry, initiated by Beiersdorf UK Ltd, scrutinised claims made in a December 2024 online advertisement, specifically addressing the phrases \"a new mode of action like never before\" and \"No.1 dermatologist recommended brand in the UK.\" This highlights the ongoing need for rigorous substantiation and transparent communication within the beauty industry's advertising practices.

During the investigation, the ASA meticulously examined the evidence provided by La Roche-Posay. Regarding the claim of a \"new mode of action,\" the authority found sufficient scientific data to support that the active ingredient, Melasyl, operates through a mechanism distinct from existing treatments for hyperpigmentation. This finding validated the innovative aspect of the product's formulation.

Similarly, the assertion that La Roche-Posay is the \"No.1 dermatologist recommended brand in the UK\" was also deemed to be substantiated. The brand presented survey data from UK dermatologists, which the ASA accepted as credible proof for this ranking. These two points of contention were therefore rejected as misleading by the regulatory body.

However, one significant aspect of the complaint was upheld. The ASA ruled that the advertisement fell short in providing clear and accessible information for consumers to verify the \"No.1\" claim. This lack of transparent signposting for comparative claims was identified as a breach of UK advertising regulations. Consequently, the advertisement in its current form is prohibited from being published again.

This decision by the ASA serves as a critical reminder to beauty companies about the dual responsibility they bear in advertising. Not only must all comparative claims be rigorously supported by evidence, but advertisers must also ensure that the basis for these claims is readily accessible and verifiable by the public. Future advertising campaigns must incorporate clearer signposting to comply with these regulatory standards.

In essence, the ruling on La Roche-Posay's Mela B3 Cleanser advertisement underscores the necessity for beauty sector advertisers to uphold stringent standards of both factual accuracy and consumer accessibility in their marketing efforts. Brands must not only prove their claims but also empower consumers to independently verify them, fostering greater trust and transparency in the marketplace.